These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5037574)

  • 1. Immune inhibition of Mycoplasma pneumoniae .
    Coleman LH; Lynn RJ
    Proc Soc Exp Biol Med; 1972 Jun; 140(2):383-6. PubMed ID: 5037574
    [No Abstract]   [Full Text] [Related]  

  • 2. Heat lability of rabbit anti-Mycoplasma pneumoniae serum.
    Coleman LH; Lynn RJ
    Antonie Van Leeuwenhoek; 1972; 38(2):193-200. PubMed ID: 4537444
    [No Abstract]   [Full Text] [Related]  

  • 3. More sensitive methods for detection of antibody to Mycoplasma pneumoniae.
    Brunner H; Horswood RL; Chanock RM
    J Infect Dis; 1973 Mar; 127():Suppl:S52-5. PubMed ID: 4570127
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of complement-dependent and independent systems in immune inactivation of Mycoplasma meleagridis.
    Matsumoto M; Yamamoto R
    J Infect Dis; 1973 Mar; 127():Suppl:S43-51. PubMed ID: 4734701
    [No Abstract]   [Full Text] [Related]  

  • 5. Nature of the serum heat-labile accessory factor involved in the metabolic inhibition of Mycoplasma pneumoniae.
    Coleman LH; Lynn RJ; Patrick RA
    Antonie Van Leeuwenhoek; 1974; 40(3):401-7. PubMed ID: 4212190
    [No Abstract]   [Full Text] [Related]  

  • 6. A study on the role of complement in the immune inhibition of mycoplasmal growth.
    Sethi KK; Teschner M
    Z Immunitatsforsch Allerg Klin Immunol; 1969 Nov; 138(5):458-74. PubMed ID: 4244398
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement dependent killing of Mycoplasma pneumoniae by antibody: kinetics of the reaction.
    Gale JL; Kenny GE
    J Immunol; 1970 May; 104(5):1175-83. PubMed ID: 5444336
    [No Abstract]   [Full Text] [Related]  

  • 8. Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
    Tamura N; Nelson RA
    J Immunol; 1967 Sep; 99(3):582-9. PubMed ID: 6051385
    [No Abstract]   [Full Text] [Related]  

  • 9. Opsonin-reversible resistance of Mycoplasma pneumoniae to in vitro phagocytosis by alveolar macrophages.
    Powell DA; Clyde WA
    Infect Immun; 1975 Mar; 11(3):540-50. PubMed ID: 1090535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune precipitation of not cell-bound antigen of Mycoplasma pneumoniae.
    Eng J
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(6):754-8. PubMed ID: 5003325
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunochemical analysis of Mycoplasma pneumoniae. 2. Properties of chloroform-methanol extract from M. pneumoniae.
    Lemcke RM; Plackett P; Shaw EJ; Marmion BP
    Aust J Exp Biol Med Sci; 1968 Apr; 46(2):123-39. PubMed ID: 4297746
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of complement in immune inactivation of Mycoplasma gallisepticum.
    Barker LF; Patt JK
    J Bacteriol; 1967 Aug; 94(2):403-8. PubMed ID: 4962702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct haemagglutination by Mycoplasma pneumoniae and its inhibition by immune serum.
    John TJ; Stahl M; Fulginiti VA
    J Med Microbiol; 1969 May; 2(2):131-5. PubMed ID: 4980697
    [No Abstract]   [Full Text] [Related]  

  • 14. The evaluation of the metabolic-inhibition technique for the study of Mycoplasma gallisepticum.
    Taylor-Robinson D; Berry DM
    J Gen Microbiol; 1969 Jan; 55(1):127-37. PubMed ID: 5775117
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of mycoplasmas isolated from the great apes.
    Cole BC; Ward JR; Golightly-Rowland L; Graham CE
    Can J Microbiol; 1970 Dec; 16(12):1331-9. PubMed ID: 4939754
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to mycoplasma in sera of leukemic patients.
    Murphy WH; Ertel IJ; Bullis C; Zarafonetis CJ
    Proc Soc Exp Biol Med; 1967 Feb; 124(2):366-72. PubMed ID: 6019872
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA replication in Mycoplasma laidlawii B.
    Smith DW
    Biochim Biophys Acta; 1969 Apr; 179(2):408-21. PubMed ID: 4890600
    [No Abstract]   [Full Text] [Related]  

  • 18. Heat-labile accessory factor involved in vaccinia virus plaque neutralization.
    O'Brien TC; Hannah JE; Tauraso NM
    Arch Gesamte Virusforsch; 1973; 40(3):366-74. PubMed ID: 4735532
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody response of animals to Mycoplasma pneumoniae measured by latex agglutination.
    Kende M
    Appl Microbiol; 1969 Feb; 17(2):275-9. PubMed ID: 4975657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by normal rabbit sera of the growth of T-mycoplasma strains isolated from different animal species.
    Howard CJ; Gourlay RN
    J Gen Microbiol; 1973 Oct; 78(2):277-85. PubMed ID: 4762919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.